Cargando…
Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients
Chronic pain and substance use disorders frequently co-occur. Indeed, chronic pain is highly prevalent, affecting 23–68% of patients receiving opioid agonist treatments (OAT) worldwide. The majority of available estimates come from American studies, but data are still lacking in Europe. We aim to pr...
Autores principales: | Delorme, Jessica, Pennel, Lucie, Brousse, Georges, Daulouède, Jean-Pierre, Delile, Jean-Michel, Lack, Philippe, Gérard, Antoine, Dematteis, Maurice, Kabore, Jean-Luc, Authier, Nicolas, Chenaf, Chouki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107279/ https://www.ncbi.nlm.nih.gov/pubmed/33981257 http://dx.doi.org/10.3389/fpsyt.2021.641430 |
Ejemplares similares
-
Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions
por: Delorme, Jessica, et al.
Publicado: (2018) -
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use
por: Bertin, Célian, et al.
Publicado: (2022) -
Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019) -
Detection of methadone and buprenorphine in urine samples from inmates of German prisons
por: Franchetti, Giorgia, et al.
Publicado: (2023) -
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
por: Hassan, Rahimah, et al.
Publicado: (2020)